pharmacokinetics of glp-1 receptor agonists Pharmacogenetics Glucagon-like-peptide-1 in diabetes management Recent updates on GLP-1 agonists:
Description
Learn about the Ozempic blindness lawsuit, including NAION and other vision problems, and read about the study linking semaglutide use to severe eye problems.

Insurers find themselves in the position of needing to say "yes" or "no" to GLP-1 drugs as more people seek them for weight loss

bimagrumab) may improve the body composition during WL and are in early phase clinical trials

The aim of this literature review is to discuss evidence from basic science, human studies, and clinical trials to support the preferential use of GLP-1 RAs in asthma patients with co-occurring diabetes and obesity

This class of drugs is commonly called glucagon-like peptide 1 (GLP-1) agonists.GLP-1 Agonists What is it?
